|
|
|
Insider
Information: |
Gilman Steven C |
Relationship: |
|
City: |
Lexington |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
142,930 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$726,820 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
142,930 |
|
|
Total
Value |
$726,820 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
9.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Keryx Biopharmaceuticals Inc |
KERX |
Director |
2018-12-12 |
0 |
2016-05-26 |
0 |
Premium* |
|
Contrafect Corp |
CFRX |
CEO, Director |
2017-07-25 |
20,800 |
2016-07-27 |
0 |
Premium* |
|
Momenta Pharmaceuticals Inc |
MNTA |
Director |
2020-10-01 |
0 |
2018-06-20 |
0 |
Premium* |
|
Vericel Corp |
VCEL |
|
2024-05-01 |
11,000 |
2018-09-04 |
0 |
Premium* |
|
Akebia Therapeutics, Inc. |
AKBA |
|
2023-06-06 |
87,130 |
2018-12-12 |
0 |
Premium* |
|
Scynexis Inc |
SCYX |
|
2023-06-15 |
24,000 |
2020-12-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2020-08-05 |
4 |
AS |
$32.75 |
$425,750 |
D/D |
(13,000) |
7,796 |
0 |
% |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2020-07-22 |
4 |
AS |
$33.23 |
$332,300 |
D/D |
(10,000) |
7,796 |
0 |
% |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2020-07-29 |
4 |
AS |
$29.70 |
$297,000 |
D/D |
(10,000) |
7,796 |
0 |
% |
|
VCEL |
Vericel Corp |
|
|
2021-10-27 |
4 |
AS |
$50.57 |
$252,870 |
D/D |
(5,000) |
3,500 |
0 |
% |
|
VCEL |
Vericel Corp |
|
|
2021-09-30 |
4 |
AS |
$48.85 |
$244,255 |
D/D |
(5,000) |
3,500 |
0 |
% |
|
VCEL |
Vericel Corp |
|
|
2018-12-03 |
4 |
AS |
$17.75 |
$150,908 |
D/D |
(8,500) |
0 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2020-08-05 |
4 |
OE |
$10.63 |
$138,190 |
D/D |
13,000 |
20,796 |
0 |
- |
|
VCEL |
Vericel Corp |
|
|
2019-02-28 |
4 |
AS |
$18.02 |
$135,129 |
D/D |
(7,500) |
0 |
0 |
- |
|
VCEL |
Vericel Corp |
|
|
2019-05-01 |
4 |
AS |
$16.81 |
$126,095 |
D/D |
(7,500) |
0 |
0 |
- |
|
VCEL |
Vericel Corp |
|
|
2018-09-04 |
4 |
AS |
$12.03 |
$108,270 |
D/D |
(9,000) |
0 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2020-07-22 |
4 |
A |
$10.63 |
$106,300 |
D/D |
10,000 |
17,796 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2020-07-29 |
4 |
OE |
$10.63 |
$106,300 |
D/D |
10,000 |
17,796 |
0 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
|
|
2020-06-08 |
4 |
AS |
$12.08 |
$55,169 |
D/D |
(4,567) |
38,864 |
0 |
% |
|
CFRX |
Contrafect Corp |
CEO |
|
2016-07-27 |
4 |
B |
$2.48 |
$49,600 |
D/D |
20,000 |
20,000 |
2.81 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2018-06-22 |
4 |
AS |
$21.50 |
$49,321 |
D/D |
(2,294) |
3,440 |
0 |
- |
|
VCEL |
Vericel Corp |
|
|
2022-04-29 |
4 |
AS |
$30.94 |
$27,846 |
D/D |
(900) |
5,200 |
0 |
% |
|
SCYX |
Scynexis Inc |
Director |
|
2020-12-21 |
4 |
B |
$6.25 |
$25,000 |
D/D |
4,000 |
4,000 |
2.39 |
% |
|
VCEL |
Vericel Corp |
|
|
2018-09-04 |
4 |
OE |
$2.63 |
$23,670 |
D/D |
9,000 |
9,000 |
0 |
- |
|
VCEL |
Vericel Corp |
|
|
2018-12-03 |
4 |
OE |
$2.63 |
$22,355 |
D/D |
8,500 |
8,500 |
0 |
- |
|
VCEL |
Vericel Corp |
|
|
2019-02-28 |
4 |
OE |
$2.76 |
$20,700 |
D/D |
7,500 |
7,500 |
0 |
- |
|
VCEL |
Vericel Corp |
|
|
2019-05-01 |
4 |
OE |
$2.76 |
$20,700 |
D/D |
7,500 |
7,500 |
0 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
|
|
2019-11-20 |
4 |
B |
$3.43 |
$19,894 |
D/D |
5,800 |
29,731 |
0.01 |
- |
|
VCEL |
Vericel Corp |
|
|
2021-09-30 |
4 |
OE |
$3.74 |
$18,700 |
D/D |
5,000 |
8,500 |
0 |
- |
|
VCEL |
Vericel Corp |
|
|
2021-10-27 |
4 |
OE |
$3.74 |
$18,700 |
D/D |
5,000 |
8,500 |
0 |
- |
|
AKBA |
Akebia Therapeutics, Inc. |
|
|
2021-06-07 |
4 |
AS |
$3.32 |
$15,163 |
D/D |
(4,567) |
47,997 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|